Extractables And Leachables (E&L) Testing In Pharmaceutical Development: Regulatory Requirements, Analytical Methods, And Risk Assessment Strategies In 2026

Ensuring pharmaceutical product safety requires careful evaluation of potential contaminants introduced during manufacturing, packaging, storage, and drug delivery processes. One of the most critical areas of regulatory compliance in drug development is Extractables and Leachables (E&L) testing, a scientific assessment used to identify chemical compounds that may migrate into drug products from packaging materials, manufacturing components, and medical device systems.

As pharmaceutical formulations become increasingly complex particularly in biopharmaceuticals, biologics, injectable drugs, and combination products regulatory authorities are placing greater emphasis on robust E&L studies to assess toxicological risk and ensure patient safety.

Global regulators including the U.S. Food and Drug Administration, the European Medicines Agency, and international pharmacopeias expect pharmaceutical manufacturers to conduct comprehensive extractables and leachables risk assessments throughout the product lifecycle.

At Maven Regulatory Solutions, we support pharmaceutical and biotechnology organizations in developing regulatory strategies for E&L testing, toxicological risk assessment, and packaging compatibility studies, ensuring regulatory compliance across global markets.

This article explores the scientific principles, analytical methodologies, regulatory expectations, and lifecycle importance of extractables and leachables testing in modern pharmaceutical development.

Understanding Extractables and Leachables in Pharmaceutical Products

Extractables and leachables refer to chemical compounds that migrate from materials used in manufacturing, packaging, and drug delivery systems into pharmaceutical products.

These compounds may originate from:

• Container closure systems
• Plastic packaging materials
• Elastomeric components
• Drug delivery devices
• Manufacturing equipment

Understanding E&L risks is essential for ensuring product safety, regulatory compliance, and successful regulatory submissions.

Key Differences Between Extractables and Leachables

Extractables studies typically identify potential compounds, while leachables studies determine actual compounds present in the final drug product.

Why Extractables and Leachables Testing Is Critical for Drug Safety

Pharmaceutical products interact with a variety of materials throughout their lifecycle. If certain chemicals migrate into the product, they may affect:

• Drug stability
• Product efficacy
• Patient safety
• Toxicological risk

Key Safety Risks Associated with E&L

Because of these risks, regulators require E&L evaluation as part of drug product safety assessment and regulatory submission documentation.

Regulatory Expectations for Extractables and Leachables Studies

Regulatory authorities have established detailed expectations for container closure systems and packaging safety assessments.

Guidance from the U.S. Food and Drug Administration emphasizes the importance of evaluating packaging materials to ensure they do not introduce harmful contaminants into pharmaceutical products.

Key regulatory frameworks supporting E&L studies include:

These frameworks help pharmaceutical companies implement systematic risk-based E&L evaluation strategies.

How Extractables Studies Are Conducted

Extractables testing involves exposing packaging or manufacturing materials to aggressive solvent conditions designed to simulate worst-case scenarios.

Common extraction techniques include:

• Acidic solvent extraction
• Basic solvent extraction
• Organic solvent extraction
• Aqueous solvent extraction
• Accelerated solvent extraction
• Soxhlet extraction methods

Extraction Study Methodology

The objective is to identify all potentially migratable compounds present in materials.

Leachables Studies Under Real-World Conditions

While extractables simulate worst-case scenarios, leachables studies evaluate compounds that migrate into drug products during storage or use.

Leachables testing typically occurs during:

• Stability studies
• Accelerated aging studies
• Drug formulation compatibility testing

Leachables Evaluation Framework

In certain cases, interactions between packaging materials and drug formulations may produce secondary leachables, which are newly formed compounds created through chemical reactions.

Analytical Technologies Used in E&L Testing

Advanced analytical instrumentation is required to detect and identify trace-level contaminants.

Common analytical technologies include:

These techniques allow scientists to perform targeted and non-targeted chemical analysis, ensuring accurate identification of extractable and leachable compounds.

Toxicological Risk Assessment for E&L Compounds

Once chemical compounds are identified, toxicologists must determine whether their presence represents a safety risk.

Key toxicological considerations include:

• Estimated daily exposure levels
• Acceptable safety thresholds
• Toxicological reference values
• Patient population risk factors

Toxicological Risk Assessment Workflow

Risk assessments help determine whether additional mitigation strategies are required.

E&L Testing for Biopharmaceuticals and Combination Products

Biologic drug products and combination products present unique E&L challenges due to their complex formulations.

Potential E&L sources include:

• Elastomeric stoppers
• Prefilled syringes
• IV bags
• Medical device components

Because biologics may be sensitive to chemical contamination, comprehensive E&L testing is essential to ensure product stability and safety.

Emerging Trends in Extractables and Leachables Testing (2026)

The field of E&L testing continues evolving due to technological innovation and regulatory expectations.

Key Trends Shaping E&L Analysis

High-resolution analytical technologies

Advanced mass spectrometry enables detection of ultra-low-level contaminants.

Risk-based regulatory strategies

Regulators increasingly support risk-based E&L evaluation approaches.

Integration with toxicological modeling

Computational toxicology tools are improving exposure risk prediction.

Expansion of advanced drug delivery systems

New delivery technologies require expanded E&L assessment frameworks.

These developments are shaping next-generation pharmaceutical safety evaluation strategies.

How Maven Regulatory Solutions Supports E&L Regulatory Compliance

Extractables and leachables testing require multidisciplinary expertise spanning analytical chemistry, toxicology, regulatory strategy, and pharmaceutical manufacturing science.

Maven Regulatory Solutions provides regulatory consulting services including:

• E&L regulatory strategy development
• Packaging compatibility risk assessment
• Extractables and leachables study planning
• Toxicological safety evaluation support
• Regulatory submission documentation preparation
• Global compliance alignment for drug packaging systems

Our regulatory experts help pharmaceutical companies implement defensible E&L programs that support regulatory approvals and ensure patient safety.

Conclusion

Extractables and leachables testing play a critical role in ensuring pharmaceutical product safety and regulatory compliance.

By identifying potential contaminants from packaging materials and manufacturing systems, E&L studies help prevent harmful chemical exposure and support safe drug development.

As regulatory expectations continue evolving, pharmaceutical companies must implement comprehensive E&L evaluation strategies supported by advanced analytical technologies and toxicological risk assessments.

Organizations that integrate E&L testing early in product development are better positioned to achieve successful regulatory submissions and protect patient safety throughout the drug lifecycle.

Featured Snippet Optimization

What are extractables and leachables testing in pharmaceuticals?

Extractables and leachables testing identify chemical compounds that may migrate from pharmaceutical packaging materials or manufacturing components into drug products, helping ensure product safety and regulatory compliance.

FAQ – Extractables and Leachables Testing

What are extractables in pharmaceuticals?

Extractables are chemical compounds that can be released from packaging materials or manufacturing components when exposed to aggressive extraction conditions during laboratory testing.

What are leachables?

Leachables are compounds that migrate into pharmaceutical products during normal storage or usage conditions.

Why are extractables and leachables testing important?

E&L testing ensures pharmaceutical products remain safe by identifying potential contaminants that could affect product quality or patient health.

What analytical methods are used for E&L analysis?

Common techniques include GC-MS, LC-MS, ICP-MS, and high-resolution mass spectrometry.